United Therapeutics Corporation with ticker code (UTHR) have now 11 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 375 and 160 with the average target price sitting at $281.18. Given that the stocks previous close was at $214.40 this indicates there is a potential upside of 31.1%. It’s also worth noting that there is a 50 day moving average of $222.65 and the 200 day moving average is $238.64. The market capitalization for the company is 9.94B. The current share price for the company is: 212.05 USD
The potential market cap would be $13,030,145,090 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 14.43, revenue per share of 43.28 and a 10.52% return on assets.
